Control of Cardiac-specific Transcription by p300 through Myocyte Enhancer Factor-2D*

The transcriptional integrator p300 regulates gene expression by interaction with sequence-specific DNA-binding proteins and local remodeling of chromatin. p300 is required for cardiac-specific gene transcription, but the molecular basis of this requirement is unknown. Here we report that the MADS (MCM-1, agamous, deficiens, serum response factor) box transcription factor myocyte enhancer factor-2D (MEF-2D) acts as the principal conduit for cardiac transcriptional activation by p300. p300 activation of the native 2130-base pair human skeletal α-actin promoter required a single hybrid MEF-2/GATA-4 DNA motif centered at −1256 base pairs. Maximal expression of the promoter in cultured myocytes and in vivo correlated with binding of both MEF-2 and p300, but not GATA-4, to this AT-rich motif. p300 and MEF-2 were coprecipitated from cardiac nuclear extracts by an oligomer containing this element. p300 was found exclusively in a complex with MEF-2D at this and related sites in other cardiac-restricted promoters. MEF-2D, but not other MEFs, significantly potentiated cardiac-specific transcription by p300. No physical or functional interaction was observed between p300 and other factors implicated in skeletal actin transcription, including GATA-4, TEF-1, or SRF. These results show that, in the intact cell, p300 interactions with its protein targets are highly selective and that MEF-2D is the preferred channel for p300-mediated transcriptional control in the heart.

[1]  R. Kitsis,et al.  Transcriptional Coactivator p300 Stimulates Cell Type-specific Gene Expression in Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[2]  M. Komajda,et al.  Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. , 1991, The Journal of clinical investigation.

[3]  M. Nemer,et al.  A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription , 1994, Molecular and cellular biology.

[4]  C. Fisher,et al.  Modification of a PCR-based site-directed mutagenesis method. , 1997, BioTechniques.

[5]  J. Molkentin,et al.  An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo , 1994, Molecular and cellular biology.

[6]  L. Kedes,et al.  Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.

[7]  K. Webster,et al.  Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes. , 1992, The Journal of biological chemistry.

[8]  E. Olson,et al.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Livingston,et al.  Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. , 1996, Genes & development.

[10]  P. Yaciuk,et al.  p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. , 1993, Oncogene.

[11]  F. Marumo,et al.  Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. , 1998, Life sciences.

[12]  R. Kitsis,et al.  cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. , 1997, Circulation.

[13]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[14]  E. Miska,et al.  HDAC4 deacetylase associates with and represses the MEF2 transcription factor , 1999, The EMBO journal.

[15]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[16]  E. Olson,et al.  Phosphorylation of the MADS-Box Transcription Factor MEF2C Enhances Its DNA Binding Activity* , 1996, The Journal of Biological Chemistry.

[17]  R. Schwartz,et al.  Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Deng,et al.  The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Sasayama,et al.  p300 Protein as a Coactivator of GATA-5 in the Transcription of Cardiac-restricted Atrial Natriuretic Factor Gene* , 1999, The Journal of Biological Chemistry.

[20]  Andrew D. Sharrocks,et al.  Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors , 1999, Molecular and Cellular Biology.

[21]  M. Breuning,et al.  Do human chromosomal bands 16p13 and 22q11-13 share ancestral origins? , 1998, American journal of human genetics.

[22]  Michael D. Schneider,et al.  Serum Response Factor Mediates AP-1-dependent Induction of the Skeletal -Actin Promoter in Ventricular Myocytes (*) , 1996, The Journal of Biological Chemistry.

[23]  A. Harel-Bellan,et al.  The CREB-binding Protein (CBP) Cooperates with the Serum Response Factor for Transactivation of the c-fos Serum Response Element* , 1997, The Journal of Biological Chemistry.

[24]  B. Ebert,et al.  Regulation of Transcription by Hypoxia Requires a Multiprotein Complex That Includes Hypoxia-Inducible Factor 1, an Adjacent Transcription Factor, and p300/CREB Binding Protein , 1998, Molecular and Cellular Biology.

[25]  J. Chen,et al.  The SRC family of nuclear receptor coactivators. , 2000, Gene.

[26]  L. Kedes,et al.  Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[28]  David Newsome,et al.  Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300 , 1998, Cell.

[29]  L. Karns,et al.  M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. , 1995, The Journal of biological chemistry.

[30]  E. Olson,et al.  Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. , 1999, Development.

[31]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[32]  S. Orkin,et al.  CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Molkentin,et al.  Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene , 1994, Molecular and cellular biology.

[34]  Antonio Giordano,et al.  p300 and CBP: Partners for life and death , 1999, Journal of cellular physiology.

[35]  D. Livingston,et al.  Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation , 1998, Nature.

[36]  W. Sellers,et al.  E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators , 1994, Cell.

[37]  A. Giordano,et al.  p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription , 1997, The EMBO journal.

[38]  J. Molkentin,et al.  Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[41]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[42]  D. Livingston,et al.  The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Webster,et al.  Adenovirus E1A Inhibits Cardiac Myocyte-specific Gene Expression through Its Amino Terminus* , 1997, The Journal of Biological Chemistry.

[44]  N. Perkins,et al.  Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein. , 1998, Biochemical pharmacology.

[45]  L. Kedes,et al.  Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains. , 1988, Genomics.

[46]  Alan P. Wolffe,et al.  A positive role for histone acetylation in transcription factor access to nucleosomal DNA , 1993, Cell.

[47]  K. Struhl Histone acetylation and transcriptional regulatory mechanisms. , 1998, Genes & development.

[48]  J. Molkentin,et al.  Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. , 1993, The Journal of biological chemistry.

[49]  H. Weintraub,et al.  Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. , 1995, Science.

[50]  L. Kirshenbaum,et al.  Adenovirus E1A Represses Cardiac Gene Transcription and Reactivates DNA Synthesis in Ventricular Myocytes, via Alternative Pocket Protein- and p300-binding Domains (*) , 1995, The Journal of Biological Chemistry.

[51]  M. Tsai,et al.  Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. , 1995, Genes & development.

[52]  J. Molkentin,et al.  Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. , 1996, Journal of molecular and cellular cardiology.

[53]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[54]  K. Aonuma,et al.  Differential localization of atrial natriuretic peptide and skeletal alpha-actin messenger RNAs in left ventricular myocytes of patients with dilated cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[55]  A. Clerk,et al.  Cellular mechanisms of cardiac hypertrophy , 1998, Journal of Molecular Medicine.

[56]  Bruce M. Spiegelman,et al.  Towards a molecular understanding of adaptive thermogenesis , 2000, Nature.

[57]  T. Lee,et al.  Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. , 1994, The Journal of biological chemistry.

[58]  H. Masuya,et al.  Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.